Clinical Trial Update: Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma -2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tranexamic acid for treatment of residual chronic subdural hematoma is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Unity Health Toronto | Conditions: Chronic Subdural Hematoma | Phase 2 | Status: UNKNOWN